Submit a Manuscript to the Journal

Annals of Medicine

For an Article Collection on

New Advances in Clinical and Fundamental Research on Prostate Cancer

Manuscript deadline
29 February 2024

Cover image - Annals of Medicine

Article collection guest advisor(s)

Mingkun Chen, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
[email protected]

Ke Li, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
[email protected]

Cai Yi, Xiangya Hospital, Central South University, Changsha, China
[email protected]

Submit an ArticleVisit JournalArticles

New Advances in Clinical and Fundamental Research on Prostate Cancer

Prostate cancer (PCa) is one of the most common malignancies in men, characterized by high incidence and recurrence rates. Despite the continuous advancement of therapeutic options for PCa, the underlying mechanisms and drug resistance issues remain a challenge for clinicians and scientists. Therefore, there is a need for an in-depth study of new advances in clinical and basic research on PCa.

Early diagnosis and personalized treatment are key factors in improving PCa patient survival and quality of life. However, due to the heterogeneity, complexity, and diversity of PCa, conventional treatments may not meet individualized patient needs. Understanding the molecular mechanisms of PCa and the impact of the tumor microenvironment (TME) on therapeutic response is important for developing new diagnostic markers and targeted therapeutic options. Additionally, while PCa genetic testing has been gradually applied in clinical practice with the development of precision medicine, there are still technical and ethical challenges that need to be addressed.

This Article Collection aims to report on the latest advancements in clinical and basic research in the field of PCa. We welcome all forms of submissions, including but not limited to the subtopics highlighted below:

  • Mechanisms underlying the development of PCa and its relationship with genetic factors
  • Exploring the association between the tumor microenvironment and immune therapy in PCa
  • Innovations in early diagnosis and screening methods for PCa
  • New breakthroughs in personalized treatment strategies and targeted therapies for PCa

Annals of Medicine accepts the following types of articles:

  • Research Articles
  • Review Articles
  • Clinical Trials
  • Protocols
  • Case Series
  • Commentaries

When submitting your article, please select the section, ‘Oncology’, and the Article Collection, ‘New Advances in Clinical and Fundamental Research on Prostate Cancer’ from the drop-down menu on the submission system.

Please contact Sam Zhang at [email protected] with any queries and discount codes regarding this Article Collection.


Annals of Medicine is an online, open access, international journal publishing across all areas of medicine and is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team, with guaranteed response times of within 48 hours, an initial decision on whether your article will be peer reviewed within 5 working days, and a first decision on your research within an average of 22 working days.

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.